Digital Rectal Examination Remains an Important Screening Tool for Prostate Cancer

European Urology

Volumn 54, Issue 3, 2008, Pages 483-484

  Yossepowitch, Ofer ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE DISTRIBUTION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COMORBIDITY; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; EDITORIAL; HEALTH PROGRAM; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; UROLOGY;

DIGITAL RECTAL EXAMINATION; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 47949084739     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.03.105     Document Type: Editorial

References (12)

1. Lim L.S., and Sherin K. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Am J Prev Med 34 (2008) 164-170
2. Chodak G.W., Keller P., and Schoenberg H.W. Assessment of screening for prostate cancer using the digital rectal examination. J Urol 141 (1989) 1136-1138
3. Okotie O.T., Roehl K.A., Han M., Loeb S., Gashti S.N., and Catalona W.J. Characteristics of prostate cancer detected by digital rectal examination only. Urology 70 (2007) 1117-1120
4. Carroll P., Coley C., McLeod D., et al. Prostate-specific antigen best practice policy-part I: early detection and diagnosis of prostate cancer. Urology 57 (2001) 217-224
5. Schroder F.H., van der Maas P., Beemsterboer P., et al. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 90 (1998) 1817-1823
6. Bozeman C.B., Carver B.S., Caldito G., Venable D.D., and Eastham J.A. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL. Urology 66 (2005) 803-807
7. Gosselaar C., Roobol M.J., Roemeling S., and Schröder F.H. The role of the digital rectal examination in subsequent screening visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam. Eur Urol 54 (2008) 581-588
8. Nagler H.M., Gerber E.W., Homel P., et al. Digital rectal examination is barrier to population-based prostate cancer screening. Urology 65 (2005) 1137-1140
9. Yossepowitch O., Herr H.W., and Donat S.M. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J Urol 177 (2007) 1277-1282 discussion 82
10. Borden Jr. L.S., Wright J.L., Kim J., Latchamsetty K., and Porter C.R. An abnormal digital rectal examination is an independent predictor of Gleason ≥7 prostate cancer in men undergoing initial prostate biopsy: a prospective study of 790 men. Br J Urol 99 (2007) 559-563
11. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 (2006) 529-534
12. Gosselaar C., Roobol M.J., Roemeling S., van der Kwast T.H., and Schroder F.H. Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics. Prostate 67 (2007) 154-161